What Researchers Did
The authors wrote a review of how low oxygen levels (hypoxia) in brain tumors may make them resistant to radiation and anticancer drugs, and of past attempts to get around that resistance.
What They Found
This review article states that brain tumors contain extensive regions of severe hypoxia, that hypoxic cells are resistant to radiation, and that this may contribute to treatment resistance in gliomas, while no approach tried so far has produced a significant, reproducible improvement in outcomes. Hypoxia also produces resistance to many commonly used anticancer drugs. The authors note that laboratory studies suggest hypoxia may drive changes in gene expression and mutations, and may be involved in low-grade tumors becoming aggressive glioblastomas. Over 50 years, attempts to overcome hypoxia included improving tumor oxygenation, oxygen-mimetic radiosensitizers, drugs toxic to hypoxic cells, hyperthermia, and radiation regimens less affected by hypoxia. Past clinical trials gave "tantalizing suggestions" of benefit, but none has yet shown a significant, reproducible improvement.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a narrative review rather than a new trial, so it reports no new patient data, and some of its points about hypoxia and tumor evolution come from laboratory studies rather than human trials.